Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page footer now includes a new Revision: v3.6.4 tag, replacing the previous Revision: v3.6.3 tag, signaling the latest page revision.
    Difference
    0.0%
    Check dated 2026-07-28T13:45:37.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.3, indicating a newer build of the site.
    Difference
    0.0%
    Check dated 2026-06-30T01:41:20.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added recruitment notice 'No longer looking for participants' and new help/navigation sections including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading. Old heading 'Intervention / Treatment' and the previous revision label 'v3.5.5' were removed and replaced with the current revision 'v3.6.0'.
    Difference
    0.4%
    Check dated 2026-06-15T20:05:47.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This appears to be a small system-level update rather than a change to the study data or its presentation.
    Difference
    0.1%
    Check dated 2026-06-08T16:46:16.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Reid Merryman, MD has been added to the investigators list (noted on 2026-05-18 and 2026-05-04) and Philippe Armand, MD, PhD has been removed (noted on 2026-02-12, 2026-01-26, and 2023-07).
    Difference
    0.4%
    Check dated 2026-05-25T08:14:34.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor build/version update. This change represents an update to the page's revision history without altering visible content or user interactions.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.